Core Insights - Siebert Financial Corp. reported a year of growth and investment in 2025, with a revenue increase of 12% to $94.2 million compared to $83.9 million in 2024 [7] - The company expanded stock loan revenue by over 50%, reaching $29.0 million, up from $19.2 million in 2024 [7] - Retail customer net worth grew by 9% to $19.5 billion, compared to $18.0 billion at the end of 2024 [7] Financial Highlights - Revenue increased by 12% to $94.2 million in 2025 from $83.9 million in 2024 [7] - Stock borrow/stock loan revenue rose by 51% to $29.0 million from $19.2 million in 2024 [7] - Operating income decreased to $5.6 million from $17.5 million in 2024, primarily due to costs associated with new business initiatives and technology investments [7] Business Developments - Siebert made strategic investments totaling $2.4 million in FusionIQ, a digital wealth management platform, in the second quarter of 2025 [7] - The company began generating revenue from Name, Image, and Likeness (NIL) negotiation services for collegiate athletes, earning $0.6 million in 2025 [7] - An amendment to the clearing agreement with National Financial Services was made, extending the relationship through October 2030 [7] Management Commentary - The CEO emphasized the focus on long-term growth and the establishment of a diversified revenue base for future opportunities [4] - The CFO noted that the decline in operating income was a result of planned investments aimed at expanding capabilities and supporting future growth [4]

Core Insights - AirJoule Technologies Corporation achieved all five objectives set for 2025, including technology validation, product development, and strategic partnerships [2] - The company plans to transition from development to commercial deployment in 2026, with expectations to launch its first commercial products [2] Field Deployments and Technology Validation - AirJoule systems completed field deployments in four geographies, validating technology in real-world conditions [2][3] - Significant deployments included a system at Hubbard, Texas, and a collaboration with Arizona State University for independent evaluation [5] Strategic Partnerships and Agreements - AirJoule was selected as a winner in a technology competition by the Net Zero Innovation Hub for Data Centers, with plans to deploy a system in 2026 [4] - An exclusive distribution agreement was signed with TenX Investment for market access across six Gulf countries [9] Product Development and Manufacturing - The AirJoule Core system is expected to be the first commercial product, with a launch anticipated in late 2026 [15] - The AirJoule Prime system is under development for industrial-scale water production, with an operational showcase unit being assembled [9][15] Commercial Pipeline Development - AirJoule has developed a structured customer engagement process and is actively engaged with various industry verticals [9] - Strong interest in Water Purchase Agreements (WPAs) is noted, which could create recurring revenue streams [9] Balance Sheet and Liquidity - The company ended 2025 with $21.8 million in cash, and following a registered equity offering, the pro forma cash position is approximately $44 million [10] - A $15 million private placement financing was completed in April 2025, strengthening the balance sheet [10]

Core Insights - Range Impact, Inc. reported significant progress in 2025, including the acquisition of two large coal mine complexes and the divestiture of its non-core reclamation services business [4] Financial Performance - Revenues from continuing operations increased from $0 in 2024 to $3.7 million in 2025 [6] - Net income improved from a loss of $9.8 million in 2024 to a gain of $19.2 million in 2025, marking a year-over-year improvement of $29.0 million [6] - Total assets rose from $6.2 million at the end of 2024 to $123.2 million at the end of 2025 [6] - Shareholders' equity increased from $0.8 million in 2024 to $37.8 million in 2025 [6] Operational Developments - The company expanded its mineral interests from 50 acres to over 150,000 acres of coal reserves [6] - Surface land ownership increased from 1,800 acres to approximately 30,000 acres for redevelopment purposes [6] - The company acquired ownership or management responsibility for 76 mining permits in West Virginia and Kentucky, with associated estimated future reclamation obligations of $79.3 million [6] Strategic Focus - Range Impact is transitioning from a service-based business to a land ownership model, focusing on unlocking the value of owned land through reclamation activities [4] - The company aims to develop long-term solutions to environmental, social, and economic challenges, particularly in economically disadvantaged communities throughout Appalachia [5]

Core Viewpoint - OR Royalties Inc. has filed its Annual Information Form, Consolidated Annual Financial Statements, and Management's Discussion and Analysis for the year ended December 31, 2025, with Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission [1]. Company Overview - OR Royalties is a precious metals royalty and streaming company focused on Tier-1 mining jurisdictions, specifically Canada, the United States, and Australia [3]. - The company commenced activities in June 2014 with a single producing asset and now holds a portfolio of over 195 royalties, streams, and similar interests [3]. - The cornerstone asset of OR Royalties is a 3-5% net smelter return royalty on Agnico Eagle Mines Limited's Canadian Malartic Complex, which is one of the world's largest gold mines [3].

Core Insights - Curanex Pharmaceuticals is advancing its lead asset, Phyto-N, towards an Investigational New Drug (IND) submission for ulcerative colitis planned for Q4 2026, while also exploring additional therapeutic opportunities [2][6][12] Operational Highlights - The company has made significant progress in manufacturing and chemistry, manufacturing, and controls (CMC) activities, including the completion of a pilot-scale GMP batch of Phyto-N to support GLP toxicology studies [4] - A dose-range finding toxicology study in rats and dogs has been completed, identifying the maximum feasible dose with no significant adverse findings, which is crucial for the design of the pivotal GLP toxicology program [5] Regulatory Pathway - Curanex is on track to submit its first IND application for ulcerative colitis in Q4 2026, contingent on the completion of required studies and regulatory review, with plans to initiate Phase 1 clinical development in Australia [6] Intellectual Property - The company has expanded its intellectual property position by filing a Patent Cooperation Treaty (PCT) application in March 2025, covering various therapeutic areas including autoimmune diseases and viral infections [7] Pipeline Development - Beyond ulcerative colitis, Curanex is evaluating additional therapeutic opportunities across a multi-indication pipeline, which includes atopic dermatitis, COVID-19, diabetes, NAFLD, and gout [8][9] Funding Position - Following its IPO, Curanex believes it has sufficient funding to support its near-term development objectives for at least the next twelve months, allowing continued advancement of IND-enabling activities and regulatory preparations [10] Strategic Vision - The CEO emphasized the company's commitment to building a robust operational foundation and pursuing regulatory approvals for differentiated therapeutic assets to address significant unmet medical needs [3][11]

Core Viewpoint - Synergy CHC Corp. is set to release its fourth quarter and full year financial results for 2025 on April 1, 2026, before market trading begins [1]. Group 1: Financial Results Announcement - The updated date for the financial results release is April 1, 2026 [1]. - A conference call will be held at 9:00 a.m. ET / 6:00 a.m. PT featuring the CEO and CFO [2]. - A live webcast of the conference call will be available on the Investor Relations section of Synergy's website [2]. Group 2: Company Overview - Synergy CHC Corp. develops and markets consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy [3]. - FOCUSfactor is a clinically studied brain health supplement with a 25-year legacy and established distribution in the U.S., Canada, Mexico, and the U.K. [3]. - The brand is experiencing growth and expanding into new markets, with recent retail successes across various channels [3]. - Flat Tummy is a lifestyle brand focused on women's wellness and weight management, complementing Synergy's product portfolio [3].

Core Viewpoint - Future Money Acquisition Corporation successfully closed its initial public offering (IPO) of 11,200,000 units at a price of $10.00 per unit, raising gross proceeds of $112,000,000 before expenses [1] Group 1: Initial Public Offering Details - The IPO included a partial exercise of the underwriters' option to purchase an additional 1,200,000 units to cover over-allotments [1] - Each unit consists of one ordinary share and one right to receive one-fifth (1/5) of an ordinary share upon the completion of the initial business combination [1] - The units began trading on Nasdaq under the symbol "FMACU" on March 27, 2026 [1] Group 2: Private Placement - Concurrently with the IPO, the company closed a private placement of 304,000 units at the same price of $10.00 per unit, resulting in gross proceeds of $3,040,000 [2] - The private placement units are identical to those sold in the IPO, with certain limited exceptions [2] Group 3: Financial Proceeds - As of March 30, 2026, a total of $112,560,000 (or $10.05 per unit) from the IPO and private placement was deposited in a trust account established by Equiniti Trust Company, LLC [3] Group 4: Company Overview - The company is a blank check company incorporated in the Cayman Islands, aiming to enter into a merger or similar business combination with one or more businesses [4] - The company's sponsor is Future Wealth Capital Corp., with Mr. Siyu Li as the ultimate beneficial owner [4] Group 5: Legal and Management - D. Boral Capital acted as the sole book-running manager for the offering, while Torres & Zheng at Law, P.C. and Robinson & Cole LLP served as legal counsel [5]

Company Overview - KPET Ultra Paceline Corporation is a blank check company formed to effect mergers, amalgamations, share exchanges, asset acquisitions, and similar business combinations with various businesses [4] - The company is sponsored by KPET Ultra Paceline LLC, controlled by Eduardo Tamraz and KPThree Capital LLC, controlled by Karl Peterson, both of whom have over 50 years of combined experience in operational, financial, investment, and transactional activities [4] - KPThree Capital LLC is a family office with a diversified portfolio of public and private investments, focusing on operationally oriented acquisition opportunities [4] IPO Details - The company announced the pricing of its initial public offering (IPO) of 20,000,000 units at a price of $10.00 per unit, with trading set to begin on March 31, 2026, under the ticker symbol "KPET.U" on the New York Stock Exchange [1] - Each unit consists of one Class A ordinary share and one-sixth of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at an exercise price of $11.50 [1] - Deutsche Bank Securities Inc. is acting as the sole book running manager for the offering, which includes a 45-day option for the underwriter to purchase an additional 3,000,000 units at the IPO price [2] Regulatory Information - A registration statement for these securities has been declared effective by the U.S. Securities and Exchange Commission (SEC) on March 30, 2026 [3]

Core Viewpoint - Ero Copper Corp. has filed a Technical Report related to the Preliminary Economic Assessment for the Furnas Copper-Gold Project in Brazil, indicating progress in its development and potential investment opportunities [1][2]. Company Overview - Ero Copper Corp. is a Brazil-focused mining company with a diversified portfolio of copper and gold assets, operating two copper mines and a gold mine, while advancing the Furnas Copper-Gold Project through a partnership with Vale Base Metals [3][4]. Technical Report Details - The Technical Report complies with Canadian Securities Administrator's National Instrument 43-101 and supports previous disclosures made by the company [2]. - The report is accessible on the company's website and regulatory platforms such as SEDAR+ and EDGAR [2]. Operational Philosophy - The company emphasizes safety, operational excellence, and responsible mineral production as part of its operational philosophy [4]. Stock Information - Ero Copper Corp.'s shares are publicly traded on both the Toronto Stock Exchange and the New York Stock Exchange under the symbol "ERO" [4].

Group 1 - QDRO Acquisition Corp. has successfully closed its initial public offering (IPO) of 20,000,000 units at a price of $10.00 per unit, with trading commencing on March 27, 2026, under the symbol "QADRU" on the Nasdaq Global Market [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with whole warrants exercisable to purchase one Class A ordinary share at a price of $11.50 per share [1] - The company has granted Cantor Fitzgerald & Co. a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments [2] Group 2 - QDRO Acquisition Corp. is focused on identifying businesses within the financial services, digital currency, and technology sectors for potential mergers or acquisitions [2][5] - The registration statement for the securities sold in the IPO was declared effective by the U.S. Securities and Exchange Commission (SEC) on March 26, 2026 [4]